Featured Research

from universities, journals, and other organizations

Lower cancer incidence rate in patients with central nervous system disease explained

Date:
February 20, 2014
Source:
Centro Nacional de Investigaciones Oncologicas (CNIO)
Summary:
Epidemiological studies demonstrate that diseases of the central nervous system such as Alzheimer, Parkinson and schizophrenia protect against cancer. The most remarkable example is Alzheimer's disease, which can reduce the risk of suffering from cancer by up to 50%. Various theories have been put forward in an attempt to explain this relationship between diseases at a first glance seem to be so different from the pharmacological, genetic and environmental perspectives. This week, the first evidence of a molecular relationship between cancer and central nervous system diseases has been published, identifying almost a hundred genes that could explain this relationship.

Epidemiological studies demonstrate that diseases of the central nervous system such as Alzheimer, Parkinson and schizophrenia protect against cancer. The most remarkable example is Alzheimer's disease, which can reduce the risk of suffering from cancer by up to 50%. Various theories have been put forward in an attempt to explain this relationship between diseases at a first glance seem to be so different from the pharmacological, genetic and environmental perspectives. However, the available results were not consistent enough to confirm these models.

Alfonso Valencia, researcher and Vice Director of Basic Research at the Spanish National Cancer Research Centre (CNIO), publishes the first evidence of a molecular relationship between cancer and central nervous system diseases in the journal PLOS Genetics. Specifically, the work identifies almost a hundred genes which could explain this relationship.

"We had previously published that several diseases of the brain and nervous system, particularly those which have a neurodegenerative component, are associated with a lower risk of cancer. We refer to this epidemiological evidence as inverse comorbidity," explained Valencia, and added: "In spite of the evidence, we did not have the molecular details which could explain this protective effect, in other words, which genes could be behind this behaviour."

To look further into this paradoxical relationship, the authors of the study used bioinformatic analysis to compare data on the genetic expression of nearly 1,700 people from over 30 studies on diseases in the central nervous system (Alzheimer, Parkinson and schizophrenia) and cancer (colon, lung and prostate cancer)

A 100-GENE SIGNATURE

The results show that almost a hundred genes could be behind the relationship between these diseases: 74 genes which were less active in nervous system diseases were found to be more active in cancer; on the other hand, 19 genes which were more active in nervous system diseases were found to be less active in cancer

"It is precisely these genes which are inversely activated which could explain the lower risk of cancer in patients with nervous system diseases," said the authors of the study.

César Boullosa and Kristina Ibáñez, predoctoral researchers in Valencia's lab, highlighted that "up to 90% of biological processes which appear a greater presence in cancer have a reduced presence in the nervous system diseases analysed."

This data demonstrates that the "global regulation of cell activity could have a protective effect from diseases with inverse comorbidity," concluded the article.

"At the beginning of the project we did not really expect to get statistically significant results, so it was it came as a great surprise to find a clear genetic correlation between these two types of disease," admitted Valencia, who explains that it is "the first time that a molecular relationship between these diseases has systematically been found."

Among the genes identified in the study is PIN1, previously found to be related to both Alzheimer's disease and cancer, as well as genes involved in p53 and Wnt signalling pathways. The study has also identified genes related to crucial biological processes for life such as cell metabolism and communication between cells and their external environment.

DRUG REPOSITIONING

The researchers propose that this genetic association amongst illnesses could open the door to the use of antineoplastic drugs to treat some nervous system diseases, as well as the other way round. One example of this practice is bexarotene, an antineoplastic agent that has already displayed beneficial effects for treating Alzheimer's Disease in mice.

The study represents an example of the new possibilities genomics and bioinformatics can offer in a comprehensive approach to complex diseases such as cancer or nervous system disorders.


Story Source:

The above story is based on materials provided by Centro Nacional de Investigaciones Oncologicas (CNIO). Note: Materials may be edited for content and length.


Journal Reference:

  1. Kristina Ibáñez, César Boullosa, Rafael Tabarés-Seisdedos, Anaïs Baudot, Alfonso Valencia. Molecular Evidence for the Inverse Comorbidity between Central Nervous System Disorders and Cancers Detected by Transcriptomic Meta-analyses. PLoS Genetics, 2014; 10 (2): e1004173 DOI: 10.1371/journal.pgen.1004173

Cite This Page:

Centro Nacional de Investigaciones Oncologicas (CNIO). "Lower cancer incidence rate in patients with central nervous system disease explained." ScienceDaily. ScienceDaily, 20 February 2014. <www.sciencedaily.com/releases/2014/02/140220193514.htm>.
Centro Nacional de Investigaciones Oncologicas (CNIO). (2014, February 20). Lower cancer incidence rate in patients with central nervous system disease explained. ScienceDaily. Retrieved August 23, 2014 from www.sciencedaily.com/releases/2014/02/140220193514.htm
Centro Nacional de Investigaciones Oncologicas (CNIO). "Lower cancer incidence rate in patients with central nervous system disease explained." ScienceDaily. www.sciencedaily.com/releases/2014/02/140220193514.htm (accessed August 23, 2014).

Share This




More Health & Medicine News

Saturday, August 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) — An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) — Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) — Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) — It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins